Looking Back, Looking Forward Kenneth I. Kaitin From the Editor-In-Chief 30 December 2004 Pages: 313 - 314
Social Pharmacology: Integrating Pharmaceutical and Social Science Research on Drug Effects Michael Montagne Clinical and Nonclinical Drug Development 30 December 2004 Pages: 315 - 320
Social Pharmacology: Conceptual Remarks José-Luis Alloza Clinical and Nonclinical Drug Development 30 December 2004 Pages: 321 - 329
Barriers to Adherence in Elderly Heart Failure Patients Carol J. HopeJingwei WuMichael D. Murray Clinical and Nonclinical Drug Development 30 December 2004 Pages: 331 - 341
Assessing the Relationship between Investigator Global Evaluation and Acne Lesion Counts Mohamed AloshJonathan Wilkin Clinical and Nonclinical Drug Development 30 December 2004 Pages: 343 - 351
The Problem of Readability of Informed Consent Documents for Clinical Trials of Investigational Drugs and Devices: United States Considerations S. Michael Sharp Clinical and Nonclinical Drug Development 30 December 2004 Pages: 353 - 359
Basing Intention-to-Treat on Cause and Effect Criteria William H. Stewart Statistics 30 December 2004 Pages: 361 - 369
Statistical Issues in Clinical Trial Data Audit Paul Zhang Statistics 30 December 2004 Pages: 371 - 386
Unequal Center Sizes, Sample Size, and Power in Multicenter Clinical Trials Francis Ruvuna Statistics 30 December 2004 Pages: 387 - 394
Quality Assurance Practices for Pharmaceutical Industry-Based Drug Information Departments: A Review and Case Study Stacey M. FungJoyce Serrano Martin Drug Information 30 December 2004 Pages: 395 - 405
Primary Care Practitioners’ Uptake of a Secondary Care-Based Medicines Information Service in the United Kingdom Jill RutterDavid BrownPaul Rutter Drug Information 30 December 2004 Pages: 407 - 416